Guildford Misc
4-page document
Fields
Document Images
" 2. F'.!B.
ell IT'.
FI i..~ .............. .,
COPY
• . ..o
•. ,.o°..°.
......... °.°.,.~,
............ ° ..... • .....
..... °°. .......... ° .....
J
P.H.G.
1 6NOV1081
FILE .............................
p ...........................
HOLD .....................................
C P;' ................................. :
;
iii ,
RLOEIGFT
.13th November 1981
Or. T. Lambo,
Horld Health Orgnnisation,
IIHO Building,
IZII Geneva,
27 Switzerland.
Dear ToB,
Rather belatedly I write to thank you for arranging the meeting on
3Oth October. The fact is that like you I have been away from my office
for quite a lot of the time since we met.
I think from our point of view we found the meeting ~st helpful an~
it seems as if there was common ground on which ~e could base further
dialogue. My impression is that you and your coi~eagues felt the san~e.
Apart frora thanking you for making the arran~e~ent~, the objec~ of
this letter is to confir~ our invitation to your G,'ganisatlon to visit
us here and seeoour research establish~nt, Pernaos you would be good
enough to pass this invitation on to Dr. Ch'en, ~r. ~!aslroni and
Or. G1asunov as seem.s ,,~ost appropriate to you.
Apart from anything else, may I say what a personal pleasure it ~as
to see you and I hope that it will not be too long before we can ,,,-ee~
again.
With renewed thanks,
Yours~er61y,
R.L.O. ELY
_r~
b,c.c.C.H. Steu~t Lockhart~=r~
Dr. L,C,F. Blackman~
c2~
L~
0
r~O
-..j
P.S. Since this was written we have arranged by phone for your colleagues
to visit us in December. Great news.

RESTRICTED
MEETING WITH THE WHO, 30 OCTOBER 1981 - GENEVA
PRESENT :
Dr T A Lambo - Deputy Director General, WHO
Dr Ch'en - Assistant Director General, WHO and
Member of NCD*
Dr R Masironi - Specialist on Cardiovascluar
Diseases/NCD
Dr Glasumov - Director of NCD
[* NCD is a unit entitled Non-Communicable Diseases]
INTRODUCTORY COMMENTS
Dr Lambo said there had been considerable internal discussion
as to whether or not WHO should meet BAT. The subject of
smoking is politically highly sensitive, and many people would
see a meeting as weakness on the part of the WHO. Indeed,
Dr Lambo had already received three letters from England,
two from members of the BMA, which seriously questioned why
WHO were going to talk to BAT. (Neither of us know how the
leak can have occurred.)
WHO had concluded that open discussion could only be of mutual
benefit. Dr Lambo warned, however, that if the media were to
get a premature indication of the meeting, they would almost
certainly set about to destroy both the people and the organ-
isations concerned.
BAT STANCE
We explained our basic stance viz:
Hundreds of millions of people worldwide smoke,
and we believe vast numbers will continue to do
so despite the anti-smoking campaigns.
BAT acknowledges the epidemiological data, and
does not deny the statistical associations. BAT
does not, however, accept or imply that causation
has been proven.
Industry has responded quickly to the emerging
medical opinion about low delivery products,
and the consumer response thereto, by
developing and marketing a wide range of products -
so that the consumer can make an informed choice.
Largely because of legal constraints, the tobacco
industry has to date said little about its changed
products, and about the opinion of third party
medical authorities as the reduced associated
risk to health.
C~
t~
t~4
CD
~O
OO
Ctd/ .....

-2-
BAT now believes that more open dialogue with
Governments, doctors, consumers etc, is in
everyones interest - provided care is taken to
state facts regarding products and the
epidemlo~6I~gical statistics, not to interpret
the facts or to offer opinions on the primary
S&H issues.
WHO STANCE
Dr Masironi said that, despite the arguments as to causation,
WHO has no doubt that the link between smoking and cancer is
proven. For other diseases, however, the link is much less
direct; certainly for heart disease, smoking is merely one
of many contributory factors.
Apparently on the previous day Dr Richard Peto had been with
the WHO at Geneva, and he had made it clear that he was
convinced that low tar cigarettes are very much less hazardous
than high tar cigarettes.
Dr Masironi said that WHO does not regard passive smoking as
a significant health risk - although he acknowledged that it
can be highly irritating to people.
THE MEETING
Against the above background we presented a brief summary
based on the Smoking and Health "Blue Book" to Dr Masironi
and Dr Ch'en (Dr Glasumov and Dr Lambo having then left the
meeting).
We were surprised and gratified at the very open response to
our presentation. Dr Masironi in fact called for two WHO
publications
"Smoking and its Effects on Health" - 1975
"Controlling the Smoking Epedimic" - 1979
and pointed to statements that supported the development of low
delivery cigarettes. He said that the 1975 statement was
only made after many years consideration of the evidence of
studies such as the Royal College of Surgeons and the BMA 20
years study.
Dr Ch'en said several times that he would like to continue the
dialogue, and suggested a follow-up meeting in early December
in Southampton. This will be confirmed after various WHO staff
have studied the Blue Book - copies of which were left behind.
In passing, Dr Ch'en said WHO recognised that industry has
profit as its main motive, and said this was quite acceptable
to them.
CD
CD
kO
Ctd/ ....

-3-
Dr Ch'en went on to suggest that we may envisage the day when
the WHO and the tobacco industry jointly supported research,
eg the development of tobacco with desirable characteristics.
SUMMARY MEETING WITH DR LAMBO
Dr Ch'en had informed Dr Lambo briefly by telephone about our
meeting, including the proposed visit to Southampton. Dr Lambo
expressed total support for the idea - but then stressed again
the need for care lest either party should damage its position.
He cautioned making any announcement on the lines "WHO supports
BAT's view" or "BAT has convinced WHO of £heir stance".
Dr Lambo also said that clearly WHO cannot continue for ever
merely talking with BAT - or indeed with the tobacco industry
from any one country. He urged, therefore, that we try to get
other companies to accept the BAT approach so that one day WHO
could talk with 'the tobacco industry'.
We explained briefly that we had already spoken to some
major companies and planned to talk to other companies
when the opportunity arose. (We agreed that at this stage
no mention would be made of our talks with WHO.) Dr Lambo
said he hoped that in due course the smaller tobacco companies
of the world would also hear about and adopt the BAT approach.
Although Dr Lambo stated more than once that WHO is not a
political organisation, but is concerned with the "science"
of world health, we do not underestimate the need for extreme
care in all dealings with WHO.
SUMMARY
Unless we have grossly mis-judged the situation, the meeting
would appear to have been very worthwhile.
A point of importance is the fact that we were dealing with
highly informed people (much more so than the BMA) who seemed
to accept the underlying pragmatism of the BAT approach.
Hopefully a follow-up meeting at Southampton will be agreed.
This should give the opportunity not only to show the scale
and scope of our research, but also to underline the integrity
of our total approach to smoking and health. The ultimate
aim, however, must be to create an industry approach to the
subject, which allows a continuing dialogue with the WHO and
other organisations.
L C F HLACKMAN/R L
ii November 1981
O
%,4
:.2~
O
Circulation: Mr P Sheehy Mr E A A
Bruell
